A notable correlation of our risk score with somatic mutations in gene KRAS, KEAP1, STK11, and co-occurring KRAS/KEP1A mutations was found in NSCLC (Figure 4E). This evidence concerns the gene STK11 and non-small cell lung carcinoma.